AGP Executive Report
Last update: 7 hours agoBudget Negotiations: Gov. Mikie Sherrill is signaling she may allow some “pork” spending to be added to her $60.7 billion NJ budget only if other cuts offset it, as lawmakers race to finalize a deal before the June 30 deadline. Medication Safety: The FDA announced a nationwide recall of duloxetine (generic Cymbalta) after tests found elevated levels of a potentially cancer-causing chemical; New Jersey-based Breckenridge Pharmaceuticals is recalling specific lots distributed across the country. Water & Beach Health: Elevated fecal bacteria levels are triggering beach closures and swimming advisories in multiple states, with health risks ranging from GI illness to skin and respiratory infections. Cannabis Access Delays: Cannabis “social consumption” lounges are still waiting on supplemental licenses and local approvals, leaving some operators out of the opening window months after regulations passed. Healthcare Logistics: Fujifilm opened a new endoscopy warehouse in Fairfield, NJ, aiming to expand service capacity and support growing demand. Workplace Wellness Trend: A viral “natural Ozempic” gelatin drink is being promoted online; a NJ dietitian says it may increase fullness temporarily, but experts warn against treating it like proven weight-loss medication.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.